Table 2.
Medications and MRCI.
| Variable | Descriptive Statistics/Frequency | |
|---|---|---|
| n | % | |
| Medications | ||
| 0–4 | 239 | 43.3% |
| ≥5 | 271 | 49.01% |
| ≥10 | 42 | 7.61% |
| High-risk medication | 266 | 48.19% |
| Patients exposed to DDIs | 422 | 76.45% |
| Patients exposed to SDIs | 310 | 56.16% |
| MRCI Initial (before the oncological context) | ||
| Mean, median (SD, IQR) | 18.67, 16.00 (12.60, 9.38–24.63) | |
| MRCI Final (after the oncological context) | ||
| Mean, median (SD, IQR) | 27.39, 23.75 (16.67, 16.00–38.00) | |
| MRCI—Sections (after the oncological context) | ||
| Section A—Dosage Form, mean (SD) | 2.07 (2.02) | |
| Section B—Dosing Frequency, mean (SD) | 6.48 (4.42) | |
| Section C—Additional Instructions, mean (SD) | 18.8 (11.7) | |
Abbreviations: DDIs, drug–drug interactions; SDIs, severe drug interactions; MRCI, Medication Regimen Complexity Index; SD, standard deviation; IQR, Interquartile Range.